Abstract : Previous studies have reported elevated serum soluble thrombomodulin sTM concentrations in acute pulmonary thromboembolism APTE , but no study has evaluated the relationship between the serum sTM concentration and prognosis. In the present study we investigated the correlation between the serum sTM concentration on admission and the duration of oxygen supplementation in patients admitted to the coronary care unit CCU for APTE to evaluate whether serum sTM is a useful predictor of treatment response. The study included 38 consecutive patients 14 men, 24 women ; mean SD age 59.9 16.8 years admitted to the CCU between March 2012 and July 2014 with a diagnosis of APTE con rmed by contrast-enhanced computed tomography within 7 days of onset. The severity of pulmonary embolism was classi ed as collapse and cardiac arrest type in three patients 8 , massive type in two 5 , submassive type in 19 50 , and nonmassive type in 14 38 . Signi cant positive correlations were found for both age and creatinine clearance with duration of hospitalization, but not with duration of oxygen supplementation. There was a signi cant positive correlation between admission sTM concentrations and both days of hospitalization R 0.57, P 0.005 and duration of oxygen supplementation R 0.56, P 0.01 . The ndings of the present study suggest that serum sTM concentrations are promising predictors of treatment response and short-term prognosis in patients with APTE.
Introduction
Mortality during the acute phase of acute pulmonary thromboembolism APTE has been reported to be in the range 7 -14 1 . In particular, patients presenting with shock caused by decreased cardiac output after substantial occlusion of the pulmonary vascular bed patients with collapse and cardiac arrest-type or massive-type pulmonary embolism have been reported to have a poor prognosis [1] [2] [3] . However, because poor prognosis is also observed in patients with submassive and non-massive types of pulmonary embolism in whom circulatory dynamics are
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stable, a predictor for prognosis other than hemodynamics is needed 4 .
Some studies have evaluated relationships of B-type natriuretic peptide and troponin T with the severity of APTE 5, 6 , but no previous studies have focused on the relationship between treatment response and serum soluble thrombomodulin sTM concentrations in patients with pulmonary embolism.
In the present study we examined the correlation between serum concentrations of sTM, a blood biochemical marker, at the time of admission and the duration of either oxygen supplementation or hospitalization to determine whether sTM can be used as a predictor of treatment response.
Methods
The study was performed on 38 consecutive patients 14 men, 24 women ; mean SD age 59.9 16.8 years ; mean duration of hospitalization 19.9 8.8 days admitted to the coronary care unit CCU of Showa University Hospital between March 2012 and July 2014 with a diagnosis of APTE, con rmed by contrast-enhanced computed tomography, within 7 days of onset Table  1 . Patients with autoimmune diseases, 7, 8 renal failure creatinine Cr 2.0 mg / dl 9 , current or previous arterial thrombosis [10] [11] [12] [13] , or liver failure 14, 15 , all of which can affect serum sTM concentrations, were excluded from the study. After hospitalization, anticoagulant therapy was administered to all patients and thrombolysis was performed in patients with unstable hemodynamics or those who were considered by their attending physicians to need such therapy. Data are given as the mean SD or as n . BMI, body mass index ; CVD, cardiovascular disease Blood samples were collected from patients on admission before the initiation of anticoagulant therapy or thrombolysis. Serum sTM concentrations were determined in the 38 patients using a commercially available ELISA for the measurement of thrombomodulin TM in the blood Kyowa Medex, Tokyo, Japan . In addition, concentrations of blood coagulation markers, namely D-dimer, thrombin-antithrombin complex TAT , prothrombin fragment PTF 1 2, and plasminogen activator inhibitor-1 PAI-1 , were determined. The relationships of these markers with the duration of hospitalization and the duration of oxygen supplementation were compared between patients undergoing and not undergoing thrombolysis.
Oxygen supplementation was initiated if a patient s oxygen saturation So 2 fell below 95 on room air. Oxygen supplementation was discontinued when a patient s So 2 could be maintained at ≥ 95 . Of the 26 patients requiring oxygen supplementation, three were excluded from analyses of the relationship between the duration of oxygen supplementation and biochemical markers because they initiated home oxygen therapy following discharge. In addition, one patient who died of recurrent pulmonary embolism was excluded from analyses of relationships of the duration of oxygen supplementation and hospitalization with biochemical markers.
Statistical analysis
The signi cance of differences between the two patient groups was evaluated using Student s t-test, whereas Tukey s honestly significant difference HSD test was used for comparisons among four groups. Differences were considered significant at two-tailed P 0.05. Simple regression analysis was performed to evaluate the relationship between serum sTM concentrations and the severity of pulmonary embolism, duration of hospitalization, and the duration of oxygen supplementation. Statistical analyses were performed using JMP Pro 12 SAS Institute, Cary, NC, USA .
Ethics
This study was approved by the Ethics Committee of Showa University School of Medicine Approval no. 1703 .
Results
The baseline clinical characteristics of the patients are given in Table 1 . In terms of the severity of pulmonary embolism, three patients 8 were classi ed as collapse and cardiac arrest type, two 5 were classi ed as massive type, 19 50 were classi ed as submassive type, and 14 37
were classi ed as non-massive type. Of these patients, three with collapse, two with massive, 16 with submassive, and 10 with non-massive type pulmonary embolism underwent thrombolysis. Of the patients undergoing thrombolysis, three two with submassive and one with non-massive type pulmonary embolism developed bleeding as an adverse event. Table 2 shows the correlation between blood coagulation markers and the duration of oxygen supplementation. There was a signi cant positive correlation between D-dimer and the duration of oxygen supplementation. However, the correlation between serum sTM concentrations and the duration of oxygen supplementation was more significant R 0.56, P 0.01 than that between D-dimer and duration of oxygen supplementation. There were signi cant correlations between the duration of hospitalization and both age R 0.36, P 0.01 and Cr clearance R 0.32, P 0.05 . However, oxygen supplementation was not signi cantly correlated with either age or Cr clearance.
There were signi cant positive correlations between admission serum sTM concentrations and both the duration of hospitalization R 0.57, P 0.005 and the duration of oxygen supplementation R 0.56, P 0.01 ; Fig. 1 . There were no signi cant differences in the duration of hospitalization or oxygen supplementation between the groups undergoing and not undergoing thrombolysis Fig. 2 .
In evaluating the relationship between the severity of pulmonary embolism and the duration Fig. 1 . Correlations between serum soluble thrombomodulin sTM concentrations and the duration of hospitalization and oxygen supplementation. There were significant positive correlations between serum sTM concentrations and both the duration of hospitalization and the duration of oxygen supplementation. of oxygen supplementation, the duration of oxygen supplementation in the cardiac arrest and collapse group was signi cantly greater than in the submassive and non-massive groups Fig. 3 . In addition, serum sTM concentrations were signi cantly higher in the cardiac arrest and collapse group than in the non-massive group Fig. 3 .
Discussion
TM is a membrane protein present on vascular endothelial cells that binds to thrombin, thereby augmenting protein C activation and inhibiting thrombin coagulation activity. If endothelial cells are damaged, the TM expressed on endothelial cells is cleaved from the cell membrane and the cleavage product is detectable in a soluble form sTM in the circulating peripheral blood. Thus, sTM can be a marker of damage to endothelial cells [16] [17] [18] [19] [20] .
It is known that sTM is metabolized by the liver and is excreted through the kidneys, and that sTM levels are elevated in a variety of diseases, including disseminated intravascular coagulation, acute respiratory distress syndrome, and collagen diseases 21 . In addition, elevated blood sTM levels have been reported in patients with acute pulmonary embolism, with the mechanism responsible considered to involve an increased release of TM as a result of damage to pulmonary artery endothelial cells 21 .
The present study demonstrated a significant correlation between the duration of oxygen supplementation and serum sTM concentrations. The mechanism is speculated to involve an increase in the release of TM from endothelial cells as a result of more pulmonary vascular beds being damaged by blood clots. This may result in elevated serum sTM concentrations.
The difference in treatment modalities between groups undergoing and not undergoing throm- bolysis was considered to have no effect on the results evaluated herein because there was no difference in the duration of oxygen supplementation between these two groups. The American College of Chest Physicians ACCP guidelines do not recommend the use of thrombolysis in patients whose systolic blood pressure is less than 90 mmHg Grade 2C 22 . In contrast, the Japanese guidelines recognize that thrombolysis is indicated for a wider range of diseases and that thrombolysis can be considered for patients with shock, those with unstable hemodynamics, and those with right heart strain Grade 2A 1 . Thus, the frequency of thrombolysis in patients with pulmonary embolism in Japan is higher than that in Europe and the US 23 embolism was associated with a decreased risk of all-cause mortality, but with increased risks of major bleeding and intracerebral hemorrhage 25 . Thus, there is still no de nitive conclusion about whether thrombolysis is indicated for acute pulmonary embolism, and further studies are needed to evaluate its indications. The duration of oxygen supplementation tended to become longer with a higher degree of severity of pulmonary embolism. Furthermore, the present study suggests a signi cant relationship between serum sTM concentrations and the severity of pulmonary embolism. In the Fig. 3 . Evaluation of relationships between the severity of pulmonary embolism 1, collapse and cardiac arrest ; 2, massive ; 3, submassive ; 4, non-massive and the duration of oxygen supplementation and serum soluble thrombomodulin sTM concentrations. The duration of oxygen supplementation was significantly greater in the cardiac arrest and collapse group than in the submassive and non-massive groups. Serum sTM concentrations were significantly greater in the cardiac arrest and collapse group than in the non-massive group. P 0.05 ; P 0.01. The boxes show the interquartile range, with the median value indicated by the horizontal line ; whiskers show the range, and symbols indicate individual data points.
population studied herein, the number of severe cases was small, and so increasing the sample size could increase the reliability of the statistical analysis. In an aggregate survey by the Tokyo CCU Network Scienti c Committee, the rates of collapse, massive, submassive, and non-massive type pulmonary embolisms were 3 , 6 , 18 , and 46 , respectively 3 . These rates do not differ signi cantly from those obtained in the present study.
Study limitations
The present study has several limitations. First the study was retrospective in nature ; therefore, a future prospective study is needed to con rm the results reported herein. Second, only admission sTM concentrations were evaluated. Evaluation of sTM concentrations at discharge or during the late period could make the results more relevant. Third, the sample size in the present study was small. Increasing the population size would enable inclusion of a larger number of severe cases, allowing for a more reliable statistical evaluation.
Conclusion
Some studies have reported elevated sTM concentrations in acute pulmonary embolism, but no study has evaluated the relationship between sTM concentrations and oxygen supplementation. The results of the present study suggest that sTM concentrations may be a useful marker for predicting treatment response.
